In Sir Morrel MacKenzie describes papillomas as pharyngo-laryngeal lesions at a child, and the term of juvenile laryngeal papillomatosis has been introduced by Chevalier Jakson in The etiological agent is HPV types 6 and 11 and the section of the respiratory tract the most hpv laryngeal papillomatosis infected is the squamocolumelar junction. Human papillomavirus 52 positive squamous cell carcinoma of the conjunctiva Juvenile laryngeal papillomatosis is a disease more frequent between hpv laryngeal papillomatosis and 5 years, characterised by multiple relapses and exuberant growth at the level of the laryngeal mucosa.
The annual laryngeal papillomatosis spreading of the hpv laryngeal papillomatosis of this disease are over million USD. The evolution of the disease decreases the quality of the life laryngeal papillomatosis spreading the patient and malignancy and death can occur during the disease. Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease for the specialties that deal with this pathology, especially paediatrics and otolaryngologists.
The evolution of the patients with laryngeal papillomatosis depends on the early diagnosis and the corresponding treatment. Material and method: hpv laryngeal papillomatosis data from the literature of specialty and the clinical experience in the ENT Clinic in Timisoara we present actualities in the epidemiology, the diagnosis and the treatment in the juvenile laryngeal papillomatosis.
Conclusions: juvenile laryngeal papillomatosis is caused by the HPV types 6 and The treatment follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.